Gentian Diagnostics ASA (OSL:GENT)
38.00
-0.50 (-1.30%)
Mar 4, 2026, 9:37 AM CET
-23.08% (1Y)
| Market Cap | 593.76M |
| Revenue (ttm) | 176.50M |
| Net Income (ttm) | 13.26M |
| Shares Out | 15.42M |
| EPS (ttm) | 0.86 |
| PE Ratio | 44.79 |
| Forward PE | 14.69 |
| Dividend | 0.60 (1.54%) |
| Ex-Dividend Date | May 6, 2026 |
| Volume | 2,500 |
| Average Volume | 42,634 |
| Open | 39.00 |
| Previous Close | 38.50 |
| Day's Range | 38.00 - 39.00 |
| 52-Week Range | 36.10 - 65.80 |
| Beta | 0.44 |
| RSI | 27.19 |
| Earnings Date | Feb 11, 2026 |